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BACKGROUND: Recruitment of general practices and their patients into research studies is frequently reported as a challenge. The
Preventing and Lessening Exacerbations of Asthma in School-aged children Associated with a New Term (PLEASANT) trial recruited
142 general practices, across England and Wales and delivered the study intervention to time and target.
AIMS: To describe the process of recruitment used within the cluster randomised PLEASANT trial and present results on factors that
inﬂuenced recruitment.
METHODS: Data were collected on the number of and types of contact used to gain expression of interest and subsequent
randomisation into the PLEASANT trial. Practice size and previous research experience were also collected.
RESULTS: The mean number of contacts required to gain expression of interest were m= 3.01 (s.d. 1.6) and total number of
contacts from initial invitation to randomisation m= 6.8 (s.d. 3.5). Previous randomised controlled trial involvement (hazard ratio
(HR) = 1.81 (conﬁdence interval (CI) 95%, 1.55–2.11) Po0.001) and number of studies a practice had previously engaged in (odds
ratio (OR) 1.91 (CI 95%, (1.52–2.42)) Po0.001), signiﬁcantly inﬂuenced whether a practice would participate in PLEASANT. Practice
size was not a signiﬁcant deciding factor (OR= 1.04 (95% CI 0.99–1.08) P= 0.137).
CONCLUSIONS: Recruitment to time and target can be achieved in general practice. The amount of resource required for site
recruitment should not, however, be underestimated and multiple strategies for contacting practices should be considered. General
practitioners with more research experience are more likely to participate in studies.
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INTRODUCTION
Recruitment of general practices (GPs) and their patients into
research studies is often reported as a challenge.1–3 This difﬁculty
in recruitment has a negative impact on recruitment targets,
delivery to pre-planned timelines and associated costs, which can
have implications for the validity of the ﬁndings and how
representative they may be.2,4
A survey of UK primary care studies reported that 56% of
studies extended the recruitment period, 44% increased the
number of sites, and 31% sought additional funding in order to
complete the trial.5 The additional resource sometimes required to
complete studies in primary care can discourage both researchers
and funders. Although there has been published guidance on
the principles of improving recruitment in primary care2 and
information from systematic reviews of recruitment in clinical trials
generally,6 the lack of evidenced-based recommendations makes
targeting interventions for improving recruitment difﬁcult. As such
the process of recruitment remains complex and challenging.
Randomised control trials that recruit from GPs and achieve
recruitment targets can add to the evidence base by reporting the
process of recruitment and characteristics of the participating
primary care sites. The PLEASANT trial (Preventing and Lessening
the Exacerbation of Asthma in School-aged children Associated
with a New Term) recruited from GPs to time and exceeded target.
This paper will report the experience of the PLEASANT trial and
factors that contributed to practices expressing an interest
and actual participation in the trial. Characteristics of recruited
practices were analysed to identify predictors of successful
participation.
Background to the PLEASANT trial
In the United Kingdom, there is a signiﬁcant increase in the
number of unscheduled visits to the doctor, by school-aged
children with asthma associated with the return back to school in
September after the summer holidays. This increase is preceded
by a drop in the number of asthma-related prescriptions
administered in August.7 It is possible therefore that children
might not be taking their medication as prescribed before the viral
challenge they meet on return to school and from picking up
infections that might affect their asthma.
PLEASANT is a cluster randomised controlled trial (cRCT) that
examines whether a brief intervention delivered by the GP and
the practice to the parents of school-aged children with asthma, at
the start of the summer holidays, would reduce the number of
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unscheduled medical contacts following return to school in
September of the same year.
The trial recruited 142 GPs (70 intervention and 72 control)
throughout England and Wales. The target population was school
children aged between 4 and 16 years at 1 September 2013 with a
coded diagnosis of asthma who had been prescribed asthma
medication in the previous 12 months. The intervention (a letter
sent from the practitioner signed by a GP to parents/carers of
children with asthma reminding them to maintain their child’s
medication and collect a prescription if they are running low) was
delivered at the start of the school summer holidays w/c 29 July
2013. Docmail (a secure web-based postal service8) was
encouraged as a vehicle for sending the intervention to reduce
the research burden to sites. This also facilitated monitoring the
timing of the intervention and the numbers of letters sent.
The primary outcome was the proportion of patients who have an
unscheduled medical contact in September 2013 (see Horspool
et al.9 for full details of the trial).
METHODS
Recruitment to the PLEASANT trial took place over a 7-month period from
January 2013 to July 2013. This was a ﬁxed recruitment period, with no
possibility of extension due to the timing of the intervention, with a target
recruitment sample size of 140. GPs in England and Wales, linked to the
Clinical Practice Research Datalink (CPRD),10 were invited to participate in
the PLEASANT trial (n=433). CPRD is a computerised database that is able
to access pseudonymised routine medical records from primary care—the
database holds information on all medical contacts and records the type of
contact based on system codes. CPRD was used due to the amount of
follow-up data required—the study collected all medical contacts—for
children diagnosed with asthma, over a 2-year period (12 months pre- and
post intervention).
The National Institute for Health Research, Primary Care Research
Networks (PCRN) also advertised the study and supported recruitment. The
eligibility criteria were that had to be using Vision software system
(London, UK) (as this is the software that was linked to CPRD at the time),
and had to be willing to join CPRD and supply data if they were not
already.
Recruitment process
A staged recruitment strategy was undertaken by CPRD, which consisted
of repeat invitations by post or email to all 433 practices from England and
Wales contributing to the database. Invitations (which included a detailed
study information sheet and an expression of interest (EOI) form
developed by the study team—details can be found on the PLEASANT
website11) were sent to either the practice research lead (usually GP)
and/or practice manager depending on the practices’ preferred contact
person given when they joined CPRD. The ﬁrst contact was by postal
invitation. Practices who did not respond to the postal invitation were sent
a second invitation via email. A further two emails were sent to non-
responding practices followed by a ﬁnal, posted, letter of invitation.
A ﬁnal round of recruitment, to boost uptake towards the end of the
recruitment period, was a personal telephone call to the GP, practice
manager or lead research contact at the sites. The telephone calls were
conducted either by CPRD or by members of the study team including a
research assistant and trial manager who are based in the Shefﬁeld Clinical
Trials Research Unit (CTRU). Where practice access proved difﬁcult, the
practices were phoned by the GP member of the team.
Practices were asked to return the completed EOI (information included
practice name and address, name/email of the practice research lead,
practice manager or other study contact, practice information technology
system and Clinical Commissioning Group area) to either the CPRD or
directly to the study team. The research assistant, at the University of
Shefﬁeld, then attempted to contact the practice via telephone within 2
working days of receiving the EOI to discuss the study further and arrange
a telephone study set-up meeting. Once the set-up meeting had been
completed and the practice gave verbal consent to participate, they were
randomised, by a CTRU statistician within 48 hours and informed via email
of their allocation. Practices were asked to acknowledge receipt of
allocation. Communication from receiving the EOI to randomisation was
either by telephone or email.
Data collection (practice speciﬁc)
Data were collected on the number of times a practice was contacted and
the type of contact (postal, email or telephone). From information available
from CPRD records, data were also collected on practice size, and on the
number and type of previous studies a practice had participated in to
examine what impact this may have had on participation in PLEASANT.
Statistical analysis
The binary responses of EOI and whether or not a practice was randomised
were analysed by logistic regression. The explanatory variables: number
previous studies—in total and broken down by number of individual or
cluster randomised RCT—and practice size were individually analysed
against the outcomes. The survival-type responses time to EOI and time to
randomisation were analysed by Kaplan–Meier survival plots and Cox
regression for the same explanatory variables. For the survival end points,
censoring times were deﬁned as the last time a practice was contacted by
reminder letter, email or telephone call.
RESULTS
The ﬂow of practices through the full PLEASANT trial is shown in
Figure 1. A total of 433 practices were invited to the study by the
CPRD, 157 EOIs were received with 142 randomised in total
(including those recruited by PCRN n= 13). Practices were
excluded if they had recently changed computer system (n= 5)
or were not willing to join CPRD (n= 10 PCRN recruited practices).
Information relating to the recruitment process used by PCRN to
gain EOI is not available; therefore, those practices (n= 13) are
excluded from the remaining analysis and only those practices
recruited via CPRD are included in the results (n= 129).
The number of contacts from initial postal invitation to EOI was
m= 3.01 (s.d. 1.6), from EOI to randomisation m= 4.4 (s.d. 3.2) and
total number of contacts from initial invitation to randomisation
m= 6.8 (s.d. 3.5). Figure 2 shows the timing and type of contacts
and the cumulative response rates to EOI and randomisation.
Logistic regression analysis was undertaken to assess the
impact of previous study participation with the outcome as
randomisation status and number of previous RCTs a practice had
Figure 1. Practice recruitment.
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participated in as the explanatory variables (Figure 3). The
corresponding odds ratios, for the explanatory variables, are
found in Table 1: all models were highly signiﬁcant with Po0.001.
For the model ﬁtted to investigate whether the explanatory
variable practice size, there was no evidence of effect (P= 0.137).
Table 1 also shows the results of using EOI status as the outcome.
These results infer more of an effect for practices who had
previously participated in RCTs.
Each of the odds ratios is an odds ratio per increase in the
number of trials. Thus, the odds ratio of being in the study for
practices who have done one cluster trial compared with those
who have done none from the model is 2.42. Likewise, the odds
ratio for those who did two cluster trials compared with those
who did one is also 2.42. Although the odds ratio for those who
did two compared with those who did none from the model is
2.42 × 2.42 = 5.86.
Kaplan–Meier plots for time to randomisation broken down by
whether a practice had previously participated in a trial and the
number of trials are shown in Figure 4 where randomised status
was the event and time to randomisation used as the censoring
times. As well as whether a practice had undertaken a trial
previously, the total number of RCTs seemed to be a signiﬁcant
factor in participation.
Hazard ratios from corresponding Cox regression models are
given in Table 2. The results were similar to the logistic regression
analysis. All models and variables were highly signiﬁcant
(Po0.001) with the exception of practice size, which seemed to
not affect the time to randomisation of a practice.
It is more common for a survival analysis to be undertaken on
an undesirable outcome, which we wish to prevent—such as
mortality—and not an outcome we wish to achieve such as here
—recruitment into the study. We did a plot of the log of the
negative log of the cumulative hazards to investigate the
proportional hazards of the model. There is an initial period at
the start of the study—evident in Figure 4—when the assump-
tions may not be so strong but after this point the assumptions of
proportional hazards seem to hold.
DISCUSSION
Main ﬁndings
Recruitment to time and target can be achieved in primary care
trials though it is important to consider the amount of resource
that is required. In the PLEASANT study, there was a full-time
research assistant within the CTRU, a trial support administrator
within CPRD, as well as a trial manager and a clinically active
academic GP co-applicant, all of whom gave input to recruiting
sites during the 7-month recruitment period. Most of the practices
invited where part of the CPRD who have knowledge of the
practices and as such judgements were made about the type and
amount of invitations made to sites. Giving consideration to the
importance of time, resource and researcher effort required for
successful recruitment has been reported in other studies that also
used intense research strategies, similar to PLEASANT, to achieve
recruitment targets.12–15
Analysis also suggests having more research experience
improves participation and response rates to EOI and
randomisation.
Interpretation of ﬁndings in relation to previously published work
Practice list size has been reported as signiﬁcant with studies
reporting larger practices were more likely to participate in
research studies.16,17 However, Goodyear-Smith18 found that
larger practices were harder to recruit and, as with PLEASANT,
Down19 suggests that practice size was not a signiﬁcant factor in
predicting participation rates.
Other demographic factors previously reported as increasing
the likelihood of practice participation include practice involve-
ment in GP training3,20 higher Quality and Outcome Framework
scores,19 number of GP partners,21 whether sites are training
practices and the numbers of GPs at each practice. However, these
variables were not available from CPRD, so we are unable to state
whether any of these may have had an impact in recruitment to
PLEASANT.
Strengths and limitations of this study
The main strength of the PLEASANT trial was ease of the intervention
and data collection. On the basis of previous literature, the trial was
designed to reduce the research burden on practices and as such
there was minimal activity required from the site; patient identiﬁca-
tion was done by CPRD (based on agreed diagnostic codes) and
Docmail was used for posting the intervention. Communication with
sites was maintained throughout the recruitment period that helped
retention and ensured the intervention went out per protocol. There
was no individual patient follow-up, or data collection required from
sites as this was collected through anonymised electronic routine
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Figure 3. Randomisation and number of previous RCTs.
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medical records via CPRD. The ease of the study, assignment of
recruitment responsibility efforts to the research team, including
input from the academic GP collaborator, may have been a
contributing factor in achieving the recruitment target. The use of
a ‘discipline champion’ in aiding recruitment has also been previously
reported.22
As practices were predominantly recruited from CPRD, this
could impact on the generalisability of results. That said, some of
the practices in CPRD (n= 37) had not previously participated in
RCTs before PLEASANT. At the time of recruitment, only practices
using the Vision system were able to contribute to CPRD, so this
reduced potential participation from practice using either TPP
SystmOne or EMIS (Leeds, UK), the other two major GP computer
systems in the United Kingdom. However, CPRD’s practice
populations have been shown to be representative of the UK
GP population, the exception being a deﬁcit of children aged 0–4
years and an excess of patients aged 85 years and over23 neither
of which are the population of interest for the PLEASANT trial.
CPRD are currently working to include TPP SystmOne and EMIS
that will broaden opportunities for practice participation in the
future.
Implications for future research, policy and practice
If more experienced practices are likely to participate in future
studies, this would suggest time and investment is needed to
engage research naive settings. Previous studies have indicated
that the importance of the research question,4,21,24–28 the need for
simple studies that are not time consuming4,24,25 and that do not
affect the doctor–patient relationship4,25,27 may be the way to
encourage practice participation. The PLEASANT trial was
designed to reduce the research burden as much as possible
Table 1. Odds ratios, 95% conﬁdence intervals and P-values for logistic regression models
Dependent variable Independent variable OR (95% CI) P-value
EOI Number of previous studies 1.98 (1.57–2.51) o0.001
Number of individual RCTs 2.51 (1.71–3.78) o0.001
Number of cluster RCTs 2.16 (1.57–2.99) o0.001
Practice size (1,000's) 1.03 (0.99–1.08) 0.160
Randomised Number of previous studies 1.91 (1.52–2.42) o0.001
Number of individual RCTs 2.42 (1.65–3.61) o0.001
Number of cluster RCTs 2.07 (1.51–2.86) o0.001
Practice size (1,000's) 1.04 (0.99–1.08) 0.137
Abbreviations: CI, conﬁdence interval; EOI, expression of interest; OR, odds ratio; RCT, randomised controlled trial.
Figure 4. Time to randomisation by previous participation in RCTs and number of RCTs.
Table 2. Hazard ratios, 95% conﬁdence intervals and P-values for Cox proportional hazard models
Dependent variable Independent variable HR (95% CI) P-value
EOI Number of RCTs 1.83 (1.58–2.12) o0.001
Number of individual RCTs 2.36 (1.86–2.99) o0.001
Number of cluster RCTs 1.91 (1.52–2.40) o0.001
Practice size (1,000's) 1.03 (0.99–1.07) 0.122
Randomised Number of RCTs 1.81 (1.55–2.11) o0.001
Number of individual RCTs 2.36 (1.85–3.02) o0.001
Number of cluster RCTs 1.83 (1.45–2.32) o0.001
Practice size (1,000's) 1.04 (0.10–1.08) 0.054
Abbreviations: CI, conﬁdence interval; EOI, expression of interest; OR, odds ratio; RCT, randomised controlled trial.
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and this may have contributed to recruitment. A side product of
doing PLEASANT is that it has also increased the number of
practices in CPRD that have now participated in an RCT that would
hopefully be more likely to participate in future research.
Researchers need to consider the amount of resource and
potential strategies required to maximise recruitment as one
method alone may not produce the outcomes required.
Conclusions
Recruitment to time and target is achievable though the amount
of resource required for site recruitment should not be under-
estimated. The ease of the study, good communication, an
understanding of the context and environment of practice, and
the experience of sites may have some bearing on practice
participation and retention in primary care clinical trials. General
practices with more research experience are more likely to
participate in RCTs.
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